145 related articles for article (PubMed ID: 20715113)
1. Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients.
Wimberger P; Roth C; Pantel K; Kasimir-Bauer S; Kimmig R; Schwarzenbach H
Int J Cancer; 2011 Jun; 128(11):2572-80. PubMed ID: 20715113
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.
Aktas B; Kasimir-Bauer S; Heubner M; Kimmig R; Wimberger P
Int J Gynecol Cancer; 2011 Jul; 21(5):822-30. PubMed ID: 21613958
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.
Roth C; Pantel K; Müller V; Rack B; Kasimir-Bauer S; Janni W; Schwarzenbach H
BMC Cancer; 2011 Jan; 11():4. PubMed ID: 21211028
[TBL] [Abstract][Full Text] [Related]
5. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.
Wimberger P; Heubner M; Otterbach F; Fehm T; Kimmig R; Kasimir-Bauer S
Gynecol Oncol; 2007 Nov; 107(2):331-8. PubMed ID: 17764727
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
[TBL] [Abstract][Full Text] [Related]
7. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
[TBL] [Abstract][Full Text] [Related]
8. Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
Chebouti I; Blassl C; Wimberger P; Neubauer H; Fehm T; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 May; 7(18):26454-64. PubMed ID: 27049920
[TBL] [Abstract][Full Text] [Related]
9. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
[TBL] [Abstract][Full Text] [Related]
10. Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
Hoffmann O; Aktas B; Goldnau C; Heubner M; Oberhoff C; Kimmig R; Kasimir-Bauer S
Anticancer Res; 2011 Oct; 31(10):3623-8. PubMed ID: 21965788
[TBL] [Abstract][Full Text] [Related]
11. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
Wimberger P; Chebouti I; Kasimir-Bauer S; Lachmann R; Kuhlisch E; Kimmig R; Süleyman E; Kuhlmann JD
Gynecol Oncol; 2014 Jun; 133(3):467-72. PubMed ID: 24713547
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
[TBL] [Abstract][Full Text] [Related]
13. Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
Romero-Laorden N; Olmos D; Fehm T; Garcia-Donas J; Diaz-Padilla I
Gynecol Oncol; 2014 Jun; 133(3):632-9. PubMed ID: 24657303
[TBL] [Abstract][Full Text] [Related]
14. LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival.
Kuhlmann JD; Schwarzenbach H; Wimberger P; Poetsch M; Kimmig R; Kasimir-Bauer S
BMC Cancer; 2012 Jul; 12():325. PubMed ID: 22849543
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapy.
Kuhlmann JD; Schwarzenbach H; Otterbach F; Heubner M; Wimberger P; Worm KH; Kimmig R; Kasimir-Bauer S
Genes Chromosomes Cancer; 2011 Aug; 50(8):598-605. PubMed ID: 21563231
[TBL] [Abstract][Full Text] [Related]
17. Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy.
Berg A; Berner A; Lilleby W; Bruland ØS; Fosså SD; Nesland JM; Kvalheim G
Int J Cancer; 2007 Apr; 120(8):1603-9. PubMed ID: 17230512
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
20. Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer.
Wimberger P; Heubner M; Lindhofer H; Jäger M; Kimmig R; Kasimir-Bauer S
Anticancer Res; 2009 May; 29(5):1787-91. PubMed ID: 19443405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
